[1]叶一农, 柯伟民.重症肝炎预后影响指标的研究概况[J].临床肝胆病杂志, 2005, 21 (3) ∶184-1886.
|
[2]Kienast J, Padr T.Expression of Urokinase-type plasminogen acti-vator in atheroselerotic coronary arteries from human heart explants[J].Zhromb Haemost, 1998, 79∶579-586.
|
[3]Chavakis T, Kanse SM, Yutzy B, et al.Vitronectin concentratesproteolytic activity on the cell surface and extracellular matrixby trap-ping soluble urokinase receptor:urokinase complexcs[J].Blood, 1998, 91∶2305-2312.
|
[4]Pyke C, Kristenscn P, Ralfkiser E, et al.Urokinase-type plas-minogen activator is expressed in stromal cells and its receptor incancer cells at invasive foci in human colon adenocarcinomas[J].AmJ Biol Chem, 1996, 271∶22885.
|
[5]李德旭, 杨镇, 邱新光, 等.猪胆汁性肝纤维化的形成机制研究[J].中华实验外科杂志, 2003, 20 (1) ∶16-17.
|
[2] | Zhang XueSong, Jin Rui, Ding HuiGuo, Guo XinHui, Liu Zhuang, Zhao Min, Li HanWei. The efficacy of lipo pgel in treating chronic severe hepatitis[J]. Journal of Clinical Hepatology, 2008, 24(5): 341-343. |
[3] | Lu: Chao, Lu Jian, Xin HaiGuang, Wang JunXue. Logistic regression analysis of multiple factor that may influence the prognosis of chronic hepatic failure[J]. Journal of Clinical Hepatology, 2008, 24(6): 428-431. |
[4] | Yu XiaoHui, Sun YiBin, Liu XuYan, Zhang FangXin. Analysis of the inconsistent reason for the diagnosis of clinical and pathology of chronic severe hepatitis[J]. Journal of Clinical Hepatology, 2007, 23(6): 419-421. |
[9] | Huang LiHua, Wang JuanHua, Liu ZhiHui. Th1/Th2, Tc1/Tc2 expression in peripheral blood cell of the patients with chronic severe B viral hepatitis[J]. Journal of Clinical Hepatology, 2005, 21(2): 91-92. |
[12] | Chen Lin. Effects of lipid microspheres prostaglandin E1 injection on the treatment of chronic severe hepatitis.[J]. Journal of Clinical Hepatology, 2004, 20(2): 89-90. |
[13] | Xie XingRong, Zhan GuoQing, Deng WenQin, Li JinKe. Clinical study on phentolamine-mesilate combined diammonium-glycyrrhizinate in the treatment of chronic hepatitis gravis.[J]. Journal of Clinical Hepatology, 2004, 20(6): 351-352. |
[16] | Zheng RuiDan, Rao RiChun, Lin FuDi, Xu ZhongYu, Zhang YangGen, Zhang MinFeng. Changes of blood lipopoly saccharide activity modulating proteins and its clinical significance in patients with chronic severe viral hepatitis B[J]. Journal of Clinical Hepatology, 2002, 18(4): 212-214. |
[17] | Zhao Min, Wang HuiFen. Survival Analysis of the Patients with Chronic Severe Hepatitis[J]. Journal of Clinical Hepatology, 2000, 16(1): 50-51. |